Portfolio company
BIOIO
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops mechanism-of-action-driven therapies and a computational drug discovery platform to treat metabolic diseases and age-related conditions for the healthcare sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Gordian Biotechnology
This company develops an in vivo drug discovery platform to identify therapies for age-related diseases for the pharmaceutical and healthcare sectors.
BioAge Labs
This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.
Integrated Biosciences
The company develops small-molecule therapies for age-related diseases using a synthetic biology and machine learning platform to target cellular stress responses.
Metabolys
This biopharmaceutical company develops oral small molecules to treat metabolic diseases, specifically non-alcoholic steatohepatitis and type 2 diabetes, for the global healthcare market.
Fable Therapeutics
The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.
Metabologic
This company develops artificial intelligence-designed enzymes to improve metabolic health and longevity for consumers.
Gero
This company develops an artificial intelligence drug discovery platform to identify therapeutic targets for chronic and age-related diseases for pharmaceutical partners.
clock.bio
This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.
